ES2009917A6 - Composicion opacificante inyectable para examenes con rayos x, que contiene liposomas con elevada capacidad de encapsulado. - Google Patents

Composicion opacificante inyectable para examenes con rayos x, que contiene liposomas con elevada capacidad de encapsulado.

Info

Publication number
ES2009917A6
ES2009917A6 ES8801604A ES8801604A ES2009917A6 ES 2009917 A6 ES2009917 A6 ES 2009917A6 ES 8801604 A ES8801604 A ES 8801604A ES 8801604 A ES8801604 A ES 8801604A ES 2009917 A6 ES2009917 A6 ES 2009917A6
Authority
ES
Spain
Prior art keywords
opacifying
injectable
liposome composition
weight
encapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8801604A
Other languages
English (en)
Spanish (es)
Inventor
Michel Schneider
Herve Tournier
Bernard Lamy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco SpA
Original Assignee
Bracco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4223355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2009917(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bracco SpA filed Critical Bracco SpA
Publication of ES2009917A6 publication Critical patent/ES2009917A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES8801604A 1987-05-22 1988-05-20 Composicion opacificante inyectable para examenes con rayos x, que contiene liposomas con elevada capacidad de encapsulado. Expired ES2009917A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1991/87A CH672733A5 (US20030157025A1-20030821-C00040.png) 1987-05-22 1987-05-22

Publications (1)

Publication Number Publication Date
ES2009917A6 true ES2009917A6 (es) 1989-10-16

Family

ID=4223355

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8801604A Expired ES2009917A6 (es) 1987-05-22 1988-05-20 Composicion opacificante inyectable para examenes con rayos x, que contiene liposomas con elevada capacidad de encapsulado.

Country Status (13)

Country Link
US (3) US5312615A (US20030157025A1-20030821-C00040.png)
EP (1) EP0314764B2 (US20030157025A1-20030821-C00040.png)
JP (1) JP2619037B2 (US20030157025A1-20030821-C00040.png)
AT (1) ATE80294T1 (US20030157025A1-20030821-C00040.png)
AU (1) AU612371B2 (US20030157025A1-20030821-C00040.png)
CA (1) CA1303978C (US20030157025A1-20030821-C00040.png)
CH (1) CH672733A5 (US20030157025A1-20030821-C00040.png)
DE (1) DE3874485T3 (US20030157025A1-20030821-C00040.png)
ES (1) ES2009917A6 (US20030157025A1-20030821-C00040.png)
IL (1) IL86409A (US20030157025A1-20030821-C00040.png)
MX (1) MX9203271A (US20030157025A1-20030821-C00040.png)
WO (1) WO1988009165A1 (US20030157025A1-20030821-C00040.png)
ZA (1) ZA883449B (US20030157025A1-20030821-C00040.png)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672733A5 (US20030157025A1-20030821-C00040.png) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
MX9203504A (es) * 1988-04-20 1992-07-01 Liposome Co Inc Complejo agente: lipido activo de alta proporcion.
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
US6613306B1 (en) * 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
IN172208B (US20030157025A1-20030821-C00040.png) * 1990-04-02 1993-05-01 Sint Sa
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5447635A (en) * 1991-02-26 1995-09-05 Bracco International B.V. Process of concentration and purification of organic compounds
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
EP0665756A1 (de) * 1992-10-16 1995-08-09 SACHSE, Andreas Verfahren und vorrichtung zur herstellung flüssiger, disperser systeme
KR960702297A (ko) * 1993-05-21 1996-04-27 카롤 질레스피 리포좀 유도된 불리한 생리학적 반응감소 (reduction of liposome-induced adverse physiological reactions)
US6217849B1 (en) 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
JPH10508284A (ja) * 1993-12-15 1998-08-18 ブラッコ リサーチ ソシエテ アノニム 超音波造影媒体、この媒体を含む造影剤及び方法
ZA952485B (en) * 1994-03-28 1995-12-15 Nycomed Imaging As Liposomes
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
JPH10500999A (ja) * 1995-02-24 1998-01-27 ブラッコ リサーチ ソシエテ アノニム 血液プール画像形成造影剤としてのリポソーム懸濁液
DE19518221A1 (de) * 1995-05-10 1996-11-14 Schering Ag Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
CA2252617A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
JP4109780B2 (ja) 1998-03-06 2008-07-02 株式会社東海理化電機製作所 ギヤ機構及びウエビング巻取装置
AU757686B2 (en) * 1998-03-31 2003-03-06 New York University Liposomal bupivacaine compositions and methods of preparation
US6706280B2 (en) * 1998-08-19 2004-03-16 Bracco Research S.A. Carboxylated phosphatidic acid esters
JP3980777B2 (ja) 1998-11-02 2007-09-26 株式会社東海理化電機製作所 ウエビング巻取装置
US6426145B1 (en) 1999-05-20 2002-07-30 Scimed Life Systems, Inc. Radiopaque compositions for visualization of medical devices
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
BR0010983A (pt) 1999-05-27 2002-03-05 Euro Celtique Sa Preparações para a aplicação de agentes antiinflamatórios
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
EP1289565B1 (en) 2000-06-02 2015-04-22 Bracco Suisse SA Compounds for targeting endothelial cells
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP2005170928A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP4654590B2 (ja) * 2004-03-31 2011-03-23 コニカミノルタエムジー株式会社 Ｘ線ｃｔ用造影組成物およびその製造方法
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
WO2006009022A1 (ja) * 2004-07-21 2006-01-26 Konica Minolta Medical & Graphic, Inc. リポソーム含有ｘ線造影剤およびその製造方法
EP1776948B1 (en) * 2004-08-11 2015-12-09 Konica Minolta Medical & Graphic, Inc. Method of producing liposome-containing preparation
TW200621306A (en) * 2004-10-22 2006-07-01 Dynamis Therapeutics Inc Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
CN104274840A (zh) * 2007-12-05 2015-01-14 马维尔生物科学公司 纳米级对比剂和使用方法
AU2009257279A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
CN102438591A (zh) * 2009-03-19 2012-05-02 马维尔生物科学公司 用于增强成像对比度的组合物和方法
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
IT1404011B1 (it) 2010-12-03 2013-11-08 Uni Degli Studi Magna Graecia Di Catanzaro Nanovettore coniugato con tsh per il trattamento del cancro della tiroide
FR3017295B1 (fr) * 2014-02-07 2018-01-12 Guerbet Composition destinee a vectoriser un agent anticancereux
IL296875A (en) 2014-12-31 2022-12-01 Lantheus Medical Imaging Inc Fat-wrapped gas microsphere preparations and related methods
FR3039767B1 (fr) 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
CN115531560B (zh) 2016-05-04 2024-05-17 蓝瑟斯医学影像公司 用于制备超声波造影剂的方法及装置
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4519024A (en) * 1983-09-02 1985-05-21 At&T Bell Laboratories Two-terminal transistor rectifier circuit arrangement
US4599227A (en) * 1983-11-07 1986-07-08 Wisconsin Alumni Research Foundation Injectable pharmaceutical preparation for the induction of multiple follicular growth
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4567034A (en) * 1984-09-07 1986-01-28 E. R. Squibb & Sons, Inc. Esters of diatrizoic acid as X-ray contrast agents
CH672733A5 (US20030157025A1-20030821-C00040.png) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa

Also Published As

Publication number Publication date
US5626832A (en) 1997-05-06
CA1303978C (en) 1992-06-23
EP0314764A1 (en) 1989-05-10
ATE80294T1 (de) 1992-09-15
US5445810A (en) 1995-08-29
EP0314764B1 (en) 1992-09-09
AU612371B2 (en) 1991-07-11
JPH02500192A (ja) 1990-01-25
MX9203271A (es) 1992-07-01
DE3874485T3 (de) 2000-09-14
EP0314764B2 (en) 2000-02-02
WO1988009165A1 (en) 1988-12-01
JP2619037B2 (ja) 1997-06-11
AU1805488A (en) 1988-12-21
IL86409A (en) 1991-12-12
US5312615A (en) 1994-05-17
ZA883449B (en) 1988-11-16
IL86409A0 (en) 1988-11-15
CH672733A5 (US20030157025A1-20030821-C00040.png) 1989-12-29
DE3874485T2 (de) 1993-03-11
DE3874485D1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
ES2009917A6 (es) Composicion opacificante inyectable para examenes con rayos x, que contiene liposomas con elevada capacidad de encapsulado.
ES8505646A1 (es) Procedimiento para la preparacion de un derivado de insulina
IL111067A (en) Soft gelatin capsules and their preparation
GEP19971155B (en) Contrast medium and method for its production
SG46464A1 (en) Biocidal composition
EP0221728A3 (en) Monosaccharide containing wound healing preparation
ES2125007T3 (es) Agentes para el cuidado de la boca y de los dientes.
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
AU572612B2 (en) Isoxazole derivatives
GB2156345B (en) Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
GB2157283B (en) Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
AR040279A2 (es) Composiciones que contiene sal de sertralina
El-Mofty et al. XIX The Effect of Ototoxic Antibiotics on the Oxygen Uptake of the Membranous Cochlea
EP0271438A3 (en) Oral osmotic system for metoprolol having a specific composition
GB1391843A (en) X-ray contrast agents
GR3036481T3 (en) Medicament containing delta-aminolevulinic acid
SU1138119A1 (ru) Способ рентгенологического исследовани желудка
USD241155S (en)
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
USD239942S (en)
JPS6461426A (en) Artificial erythrocyte
Pappalardo et al. Evaluation of a disinfectant in accordance with Swiss standards.
GR3005391T3 (US20030157025A1-20030821-C00040.png)
ES458413A1 (es) Mejoras introducidas en un procedimiento de preparacion de -una composicion de anoxicilina sodica.
GB1252291A (US20030157025A1-20030821-C00040.png)

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20040521